Do fibroblasts have a role in cutaneous carcinogenesis?
News from ASCO 2016 for melanoma
Using biomarkers to predict response to combination therapies in BRAF-mutant melanoma
Trial results of vemurafenib, cobimetinib and LDH as a predictive marker in BRAF-mutated melanoma
Melanoma immunotherapy updates in 2016: clinical trials, developments and new survival data